WASHINGTON, May 1, 2017 /PRNewswire/ -- Vanda Pharmaceuticals
Inc. (Vanda) (NASDAQ: VNDA) today announced that it will deliver a
corporate presentation at the Deutsche Bank 42nd Annual
Health Care Conference in Boston,
Massachusetts on Thursday, May 4,
2017 at 8:40 a.m. Eastern
Time.
The presentation at the Deutsche Bank Health Care Conference
will be available live on Vanda's corporate website, where it also
will be archived for 30 days. To access the presentation, go to
Vanda's website at www.vandapharma.com and click on the
Presentations tab on the Investor Relations page. Please
connect to the website several minutes prior to the start of the
live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300449060.html
SOURCE Vanda Pharmaceuticals Inc.